The core of SMab™ platform lies in the modern immunological technology combined with cell sorting technology to screen single antibody-secreting cells (B lymphocytes) from immunized animals, and then amplify the antibody-coding genes obtained using modern molecular biology techniques. Thereby producing genetically engineered monoclonal antibodies with market value through large-scale in vitro expression. The specific process of rabbit monoclonal antibody development is as follows: